Featured News
Shire (a Takeda company), is the manufacturer of VYVANSE and INTUNIV which unfortunately had experienced some interruption of the supply of both medications over the Christmas holiday period. ADHD Australia has been in contact with Shire, who manufactures INTUNIV 1mg and VYVANSE 70mg, and I am pleased to advise that both products have now returned…
Read More
Shire (a Takeda company), is the manufacturer of VYVANSE who have unfortunately experienced an interruption to their manufacturing for the VYVANSE 70mg. This has resulted in a shortage within Australia of this 70mg dosage strength only. They expect the supply of the VYVANSE 70mg will return to normal in February 2020. ADHD Australia has been…
Read More
ADHD Australia officially launched its new website on Thursday 5th December at a function hosted by the Westmead Hospital Foundation. At the event were representatives from each of the organisations involved in the collaborative approach made to the funder of the project, IMB Bank Community Foundation. IMB was represented by Ms Rachael Core who is…
Read More
Catherine Cook had a sudden moment of clarity the day her 10-year-old son was diagnosed with attention deficit hyperactivity disorder (ADHD). “They told me it was hereditary and I thought, ‘Uh-oh, that’s me,’ the Sydney mother-of-two said. Ms Cook, 34, has a vague memory of being told she had attention deficit disorder when she was…
Read More
Mr Len Russell, CEO of ADHD Australia, attended the ADDults with ADHD’s Annual Conference in Sydney on Saturday 26th October 2019. ADDults with ADHD have been running their annual conference for many years with a wide range of speakers and topics as well as a packed auditorium. This year was no exception in that there…
Read More
The NSW Curriculum Review Interim Report is now available. It has been developed by the Review Lead, Professor Geoff Masters, as a basis for consultation on the broad directions for reform it identifies. It considers feedback from the 2018 consultation, alongside guidance from learning research, and reform initiatives from Australian and international jurisdictions. The Interim…
Read More
On Wed 16 October 2019, Prof Michael Kohn, and Mr Len Russell, our Chair and CEO respectively, attended the inaugural ‘Community Partners Summit’ conducted by Nicole Rogerson from Neurodevelopment Australia. This morning event was generously hosted by Ernst and Young in their Sydney offices. Neurodevelopment Australia is a new organisation which is looking to help…
Read More
The ADHD Australia website has recently undergone a significant facelift. We have been fortunate to have had the support of IMB Bank Foundation which has allowed us to invest in a totally new website, built from the ground up. By utilising the latest technologies our website is now a more flexible and feature rich one…
Read More
One in five parents of children with ADHD has been urged by their school to seek a different diagnosis as a means to gain funding for teacher’s aides and other support for their child at school. Teachers are pushing families of children with attention deficit hyperactivity disorder (ADHD) to try to obtain a diagnosis with…
Read More
Attention Deficit Hyperactivity Disorder is a surprisingly common condition in Australia and although we most commonly associate it with children, it’s a condition that can stay with people into adulthood, creating challenges across their whole lives. Host, Philip Clark, from the ABC Radio National’s ‘Nightlife’ program, spoke with Associate Professor Michael Kohn, Chair of ADHD…
Read More